Cesca Therapeutics Inc (KOOL)

3.91
NASDAQ : Health Care
Prev Close 3.98
Day Low/High 3.80 / 4.35
52 Wk Low/High 1.64 / 14.83
Avg Volume 602.60K
Exchange NASDAQ
Shares Outstanding 3.01M
Market Cap 11.97M
EPS -7.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Heavy Volume And Pre-Market Movement For Cesca Therapeutics (KOOL)

Heavy Volume And Pre-Market Movement For Cesca Therapeutics (KOOL)

Trade-Ideas LLC identified Cesca Therapeutics (KOOL) as a pre-market mover with heavy volume candidate

Cesca Therapeutics Announces Publication Of Results On Use Of Its Technology For Treatment Of Non-Union Fracture

Cesca Therapeutics Announces Publication Of Results On Use Of Its Technology For Treatment Of Non-Union Fracture

Data from Pilot Study Shows Promising Results for Bone Regeneration

7 Stocks Under $10 Making Big Moves

7 Stocks Under $10 Making Big Moves

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Cesca Therapeutics To Exhibit At 14th International Cord Blood Symposium

Cesca Therapeutics To Exhibit At 14th International Cord Blood Symposium

World Leaders in Cord Blood Banking and Preservation Congregate at ICBS

Weak On High Volume: Cesca Therapeutics (KOOL)

Weak On High Volume: Cesca Therapeutics (KOOL)

Trade-Ideas LLC identified Cesca Therapeutics (KOOL) as a weak on high relative volume candidate

Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results And Provides Business Update

Cesca Therapeutics Reports Third Quarter Fiscal 2016 Results And Provides Business Update

Management to Hold Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

Cesca Therapeutics Announces 1-for-20 Reverse Split Of Common Stock

Cesca Therapeutics Announces 1-for-20 Reverse Split Of Common Stock

Trading on a Post-Split Basis is Scheduled to Begin March 7, 2016

Cesca Therapeutics Announces 1-for-20 Reverse Split Of Common Stock

Cesca Therapeutics Announces 1-for-20 Reverse Split Of Common Stock

Stockholders Approve Reverse Split

Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results And Provides A Status Update To Investors

Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results And Provides A Status Update To Investors

Management Will Hold a Conference Call Today at 2:00pm Pacific (5:00pm Eastern)

Cesca Announces $15 Million Strategic Investment From Boyalife Group

Cesca Announces $15 Million Strategic Investment From Boyalife Group

Funds to be Used to Repay Current Senior Secured Convertible Debentures and Provide Additional Working Capital to Fund Ongoing Operations and Strategic Initiatives